All Things Cancer | National Foundation for Cancer Research
National Foundation for Cancer Research
0
Join Dr. Sujuan Ba, CEO of the National Foundation for Cancer Research, as she interviews leading scientists, advocates, researchers, and patients shaping the future of cancer research and care. Each episode explores groundbreaking discoveries, personal stories, and transformative ideas in the fight against cancer, from lab innovations to patient resilience.
Episodes
-
Breast Cancer Was Supposed to End by 2020. Fran Visco Explains What Happened. 26.10.2026 43mWhat does it take to turn a breast cancer diagnosis into a movement that changed how cancer research is funded? On this episode of All Things Cancer, Dr. Sujuan Ba, CEO of the National Foundation for Cancer Research (NFCR), sits down with Fran Visco, President of the National Breast Cancer Coalition (NBCC), for a candid conversation about patient advocacy, cancer research funding, and the push for bolder science.Fran was a lawyer, wife, and mother when she was diagnosed with breast cancer in 1987. She went on to help build NBCC into one of the most influential patient advocacy organizations in... -
The Awkward Mistake That Sparked a 25-Year Cancer Research Partnership 04.09.2026 50mFrom a graduate student who couldn't reliably spell "genetics" to the scientist who provided the first experimental evidence for the class of gene now called "tumor suppressors" — Dr. Webster "Web" Cavenee's career changed how we understand and treat cancer.In this episode, Dr. Cavenee sits down with NFCR President & CEO Dr. Sujuan Ba to trace a friendship and scientific partnership that's spanned more than 25 years — starting with a name Cavenee accidentally botched at a conference podium. From there, the conversation moves through his landmark discovery of the first tumor suppressor gene, th... -
From Frogs to Algorithms: The Unlikely Duo Rewriting Breast Cancer Research 28.08.2026 35mWhat happens when a cancer biologist and a mathematician become research partners?In this episode of All Things Cancer, Dr. Lisa Coussens and Dr. Elana Fertig sit down to talk about the unlikely collaboration transforming how we understand breast cancer. Lisa's path wound through art school, marine biology, and an early stint at Genentech before she became a leading cancer biologist. Elana came to science through a love of puzzles and math, eventually applying data science to weather prediction before turning her tools toward cancer research.Funded by an NFCR grant that encouraged cross-discip... -
He Held Her Foot Through Every MRI For 7 Years — Then She Was Gone 31.07.2026 42mWhen Tom Clark's wife Bernadette — a nurse and his high school sweetheart of over 50 years — began showing subtle, out-of-character symptoms, she was the one who suspected something was seriously wrong before any scan confirmed it. She was right: a brain tumor, later diagnosed as glioblastoma (GBM), one of the most aggressive cancers there is.In this episode of All Things Cancer, Tom sits down with Dr. Sujuan Ba, NFCR's President and CEO, to share the full arc of Bernadette's journey — from that first stumble on a mountain trail to brain surgery, chemo, hospice care at home, and the promise he... -
The Cancer That Has No Symptoms — Until It's Too Late 26.06.2026 45mSkin cancer is the most common cancer in the world — and the most survivable, if you catch it early. Dr. Ron Shore has spent 34 years and 28,000 patient screenings proving it. In this episode, he breaks down the three types of skin cancer, why melanoma can be silent until it's deadly, and the simple screening habits that could save your life. If you've ever skipped your annual skin check, listen to this first.Dr. Shore also shares his five essential tips for protecting yourself: get a thorough annual exam from a knowledgeable dermatologist, return for check-ups every six to twelve months, wear... -
He Spent 3 Weeks Unplugged at the Bottom of the Grand Canyon — While Accidentally Revolutionizing Cancer Treatment 11.05.2026 36mWhat happens when a curious biochemist follows his wife to California, falls in love with whitewater rafting — and accidentally makes one of the most important cancer discoveries of the 20th century?In this episode, we sit down with Dr. Tony Hunter, the 2025 St. Gyorgi Prize winner and Salk Institute legend, whose 1979 discovery of tyrosine phosphorylation laid the foundation for over 80 cancer drugs in use today. We talk about the moment the scientific world accepted his discovery, why America's cancer research dominance is now under serious threat, the "valley of death" killing promising tre... -
Your Mammogram Can Now Predict Cancer Before You Have It -- Here's the Doctor Making It Happen 09.04.2026 26mWhat if you could know your breast cancer risk at 25 and actually do something about it? Dr. Funmi Olopade, a trailblazing oncologist at the University of Chicago, has spent 30 years rewriting the rules of breast cancer care, and she believes we can eradicate it as a cause of premature death within a decade. In this episode, she breaks down how AI, genetic testing, and a simple blood test are transforming early detection, why too many women are still being failed by a broken system, and what every woman should be doing right now, no matter their age.This is a conversation that could change how... -
Doctors Gave Her 3 Years to Live. She Changed Cancer Research Instead. 06.03.2026 1h 1mAt age 37, Kathy Giusti was diagnosed with multiple myeloma and told she had just three years to live. Instead of accepting that fate, she turned urgency into action and founded the Multiple Myeloma Research Foundation (MMRF), transforming how cancer nonprofits accelerate drug development. Today, more than 15 therapies have been approved for multiple myeloma and survival rates have more than doubled.In this episode of All Things Cancer, Dr. Sujuan Ba speaks with Kathy Giusti about her new book Fatal to Fearless, the leadership and strategy required to drive progress in cancer research, and how... -
Why Was Half This Village Dying of Cancer— And No One Stopped It? 17.02.2026 39mHalf a village was dying of cancer. No one could explain why.For the Season One finale of All Things Cancer, we’re ending with a story that changed the trajectory of cancer research — and saved generations of lives.What began as a keynote trip to Turkey turned into one of the most extraordinary cancer investigations in modern medicine.In this episode, Dr. Michele Carbone shares how he uncovered a deadly inherited mutation, confronted government officials, helped relocate entire villages, and identified the BAP1 gene — a discovery that transformed our understanding of mesothelioma and inherited... -
We’re Drowning in Cancer Data — And Still Missing Cures 27.01.2026 1h 1mIn this episode, Dr. Sujuan Ba is joined by Dr. Ann Barker, one of the most influential architects of modern cancer research, for a wide-ranging conversation on where the field is headed and what must change to accelerate progress.Dr. Barker shares why cancer research is at a critical inflection point, driven by an explosion of data, the rise of artificial intelligence, and the urgent need to move beyond siloed science. Together, they explore the promise and limitations of AI in oncology, the importance of high-quality and standardized data, and why collaboration across disciplines is no longe... -
One Diagnosis. Seven Years. A Lifetime of Impact. 12.12.2025 31mIn this heartfelt episode of All Things Cancer, NFCR CEO Dr. Sujuan Ba sits down with Shereen Pavlides and her daughter, Isabella Pavlides, to explore how personal loss can spark powerful action.From Isabella’s leadership through Play4TheCure and her growing Dine & Donate initiative to the lasting influence of her grandmother Esther’s seven-year journey with pancreatic cancer, this conversation highlights caregiving, resilience, and the next generation of advocates stepping up for cancer research. It’s a moving reminder of how community, compassion, and initiative help make cures possible. -
Cancer Research Is at Risk: Dr. Bertagnolli Reveals What Washington Isn’t Saying 25.11.2025 50mIn this episode of All Things Cancer, Dr. Sujuan Ba sits down with Dr. Monica Bertagnolli — surgeon, scientist, former Director of the National Cancer Institute and former Director of the National Institutes of Health — for one of the most candid and forward-looking conversations we've ever shared. Dr. Bertagnolli reflects on her journey from a cattle ranch in rural Wyoming to leading the nation’s most important scientific institutions, the challenges facing today’s cancer research ecosystem, the impact of declining federal funding, and what it will take to protect the future of discovery. She... -
The Next Frontier: Can CAR-T Therapy Finally Conquer Solid Tumors? 27.10.2025 28mWhat happens when a pioneering oncologist and a next-generation immunotherapy researcher sit down to talk about the future of cancer care?Join NFCR President and CEO Dr. Sujuan Ba as she moderates an eye-opening discussion between Dr. Brian Leyland-Jones and Dr. Avery Posey. From early detection and sequencing to CRISPR and CAR-T breakthroughs, this episode dives into the science — and the human drive — behind making cures possible. -
Beyond the Tumor: Dr. Isaac Witz’s Vision for the Future of Cancer Treatment 01.10.2025 20mIn this episode of All Things Cancer, NFCR CEO Dr. Sujuan Ba sits down with Dr. Isaac Witz, the 2023 Szent-Györgyi Prize for Progress in Cancer Research laureate and a pioneer in tumor microenvironment science. Decades before it became a central focus of oncology, Dr. Witz recognized that cancer is not just about tumor cells—it’s about the environment that surrounds them.Dr. Witz shares how he challenged conventional thinking, why keeping patients at the center of research matters, and how his discoveries reshaped cancer treatment worldwide. From immune responses inside tumors to overlooked “o... -
From Aha Moments to Breakthroughs: Dr. Drew Pardoll on Immunotherapy 08.09.2025 38mIn this episode of All Things Cancer, NFCR President and CEO Dr. Sujuan Ba sits down with Dr. Drew Pardoll, a pioneer in cancer immunology, to explore the breakthroughs reshaping cancer research. From harnessing the immune system and advancing protein, cell, and microbial engineering to launching biotech startups that translate discoveries into real treatments, Dr. Pardoll shares how innovation and collaboration are driving cures forward. Together, they also reflect on the vital role of young scientists, the importance of smarter clinical trials, and what’s next on the horizon for cancer patie... -
From Terminal to Triumph: Cheryl’s Journey Through Stage 4 Melanoma 25.08.2025 29mContinuing our Survivor Mini-Series: In this powerful episode of All Things Cancer, NFCR President and CEO Dr. Sujuan Ba sits down with Cheryl, a stage IV melanoma survivor whose determination and persistence changed the course of her life. Told she might not live to see another holiday, Cheryl refused to accept “no” for an answer. Her relentless search led her to a groundbreaking clinical trial that not only saved her life but helped shape the future of melanoma treatment and cancer research as a whole.Cheryl opens up about the shock of diagnosis, the uphill battle to find care, the side effe... -
Early Detection Isn’t Enough: How Experts Are Changing the Future of Cancer Care 07.08.2025 30mIn this powerful episode of All Things Cancer, host Dr. Sujuan Ba convenes some of the most forward-thinking voices in oncology to explore how early detection and early intervention are reshaping the future of cancer care. Featuring insights from Dr. Siddhartha Mukherjee, Dr. Samir Hanash, Dr. Steven Lipkin, Dr. Sapna Syngal, Dr. Ajay Goel, and Dr. Carlos Doti, this conversation dives into breakthroughs in biomarkers, liquid biopsies, genetic risk modeling, cancer interception, and how equitable access remains the key to meaningful progress.From the lab bench to real-world implementation, this... -
Real Talk, Real Resilience: Hope Stewart on Facing Cancer and Giving Back 09.07.2025 27mIn this inaugural episode of our special Survivor Series on All Things Cancer, NFCR President and CEO Dr. Sujuan Ba sits down with breast cancer survivor and NFCR Community Ambassador, Hope Stewart. With honesty, warmth, and insight, Hope shares her journey from diagnosis to recovery—highlighting the moments that tested her, the community that uplifted her, and the research that saved her life.From navigating a cold, clinical diagnosis to finding comfort in a compassionate care team, Hope opens up about the emotional and physical challenges of cancer treatment, and how they ultimately inspired... -
When the Money Stops: What’s at Risk in Cancer Research 03.06.2025 27mEvery cancer breakthrough begins with a single step—funding. In this episode of All Things Cancer, NFCR CEO Dr. Sujuan Ba speaks with leading researchers about the funding crisis threatening cancer research across the U.S. and beyond. From early-stage, high-risk studies to game-changing therapies now approaching clinical trials, these conversations reveal what’s possible when bold science is backed by strong support—and what’s lost when it isn’t.Hear from:Dr. Aaron Hata (Mass General Hospital)Dr. Jessica Lin (Mass General Cancer Center)Dr. Wayne Marasco (Dana-Farber Cancer Institute)Dr. Susan... -
Engineering a Cure: Dr. Rakesh Jain on Tumor Biology and Bold Ideas 23.04.2025 21mThis special edition of All Things Cancer features a powerful conversation with Dr. Rakesh Jain—pioneering scientist, educator, and longtime NFCR-supported researcher—on the eve of receiving the 2025 AACR Lifetime Achievement Award.In this inspiring episode, Dr. Jain sits down with NFCR President and CEO Dr. Sujuan Ba to reflect on his decades of groundbreaking work, including his revolutionary concept of vascular normalization, which has reshaped how we treat cancer. Together, they discuss:How unconventional thinking led to new cancer therapiesThe impact of NFCR’s early seed funding on high-r...
Popular in
The podcast also appears in the podcast charts of these countries.